Active Substance & Generic Molecule Directory
Alfacalcidol 0. in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Alfacalcidol 0. registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
9
Registered Brands
Availability in Malaysia:9 Prescription (MAL-A)
Showing 9 of 9 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL10120049X | Alfa-D 0.25mcg Capsule | 0.25 mcg | Prescription (MAL-A) | PAHANG PHARMACY SDN. BHD. | Compare → |
| MAL09061594X | Alfa-D 1.00mcg Capsule | 1.00 mcg 549.9 mg | Prescription (MAL-A) | PAHANG PHARMACY SDN. BHD. | Compare → |
| MAL07091042X | Alfacip 0.25mcg capsule | 0.25 mcg 0 | Prescription (MAL-A) | CIPLA MALAYSIA SDN BHD | Compare → |
| MAL07061574X | Alfacip 1mcg capsule | 1.3 mcg 0 | Prescription (MAL-A) | CIPLA MALAYSIA SDN BHD | Compare → |
| MAL06100623X | Medi-alpha 0.25mcg Capsule | 0.25 mcg 0 | Prescription (MAL-A) | MEGA LIFESCIENCES SDN. BHD. | Compare → |
| MAL19913218XC | ONE ALPHA CAPSULE 0.25MCG | 0.25 mcg | Prescription (MAL-A) | DKSH MALAYSIA SDN. BHD. | Compare → |
| MAL19913217XC | ONE-ALPHA CAPSULE 1MCG | 1MCG | Prescription (MAL-A) | DKSH MALAYSIA SDN. BHD. | Compare → |
| MAL06121071X | Osteo-alfa Capsule 0.25ug | 0.25 mcg 0 | Prescription (MAL-A) | MEDIDATA SDN. BHD. | Compare → |
| MAL07082986X | OsteoAlfa 1.0 ug S.G Capsules | 1.0 mcg 0 | Prescription (MAL-A) | MEDIDATA SDN. BHD. | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.